2023
DOI: 10.1186/s12879-023-08004-6
|View full text |Cite
|
Sign up to set email alerts
|

The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital

Abstract: Background The coronavirus disease 2019 (COVID-19) pandemic continues to evolve. Globally, COVID-19 continues to strain even the most resilient healthcare systems, with Omicron being the latest variant. We made a thorough search for literature describing the effects of the COVID-19 in a high human immunodeficiency virus (HIV)/tuberculosis (TB) burden district-level hospital setting. We found scanty literature. Methods A retrospective observational … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 43 publications
0
1
0
Order By: Relevance
“…In a high HIV and TB burden setting, COVID-19 has been associated with high mortality among people living with HIV. 60 A divergence is noted in the antiretroviral effective coverage figures between the modelled Thembisa 4.5 estimates and the routine coverage from webDHIS (Table 13), which could be the result of the momentum lost during the COVID-19 period.…”
Section: Hiv and Aidsmentioning
confidence: 99%
“…In a high HIV and TB burden setting, COVID-19 has been associated with high mortality among people living with HIV. 60 A divergence is noted in the antiretroviral effective coverage figures between the modelled Thembisa 4.5 estimates and the routine coverage from webDHIS (Table 13), which could be the result of the momentum lost during the COVID-19 period.…”
Section: Hiv and Aidsmentioning
confidence: 99%
“…A study done in Cape Town, South Africa compared the rate of hospitalization in different stages of HIV disease. Their study stated that the rate of hospitalization was 69% higher in stage 4 (CD4 less than 200 cells/ml) and 29 % higher in stage 2 (CD4 count was 200-499) compared to stage 1 (CD4 counts > 500 cells/ml) [ 60 ].…”
Section: Reviewmentioning
confidence: 99%